Contract notice

Information

Published

Date of dispatch of this notice: 12/11/2020

Expire date: 18/12/2020

External Reference: 2020-207010

TED Reference: 2020/S 224-550140

Contract notice

Contract notice

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

CHI Ireland
CHI Ireland
Temple Street
Dublin 1
Dublin 1
IE
Contact person: james lohan
Telephone: +353 18784877
Fax: +353 18748355
Internet address(es):
I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=178004&B=ETENDERS_SIMPLE
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

CHI invites tenders via an open competitive tender process for the provision of an analyser (s) to replace current in use instruments in the National Newborn Bloodspot Screening Laboratory
Reference number:  CHITSNNBSLAB2020 001
II.1.2)

Main CPV code

38434000  -  Analysers
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

This TENDER document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s) to replace current in use instrument(s) in the National Newborn Bloodspot Screening Laboratory (NNBSL) at Children's Health Ireland (CHI) at Temple Street, Temple Street, Dublin 1.
Tender incorporates a system which MUST be capable at a minimum of performing the following Newborn Bloodspot Screens (NBS) on 3.2 mm dried blood spot (DBS) samples.
1. Congenital Hypothyroidism (CHT) screening by thyroid stimulating hormone (TSH) measurement
2. Cystic Fibrosis (CF) screening by immunoreactive trypsinogen (IRT) measurement
3. Galactosaemia screening by
• Total galactose (galactose and galactose-1-phosphate) and
• Galactose-1-phosphate uridyl transferase enzyme (GALT) analysis
Must interfacable toSpecimen Gate™.
All associated consumable must also be included within submission.
II.1.5)

Estimated total value

Value excluding VAT: 400000.00  EUR
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

33696500  -  Laboratory reagents
II.2.3)

Place of performance

Main site or place of performance:  
CHI TEMPLE STREET DUBLIN
II.2.4)

Description of the procurement

This TENDER document defines the Department of Paediatric Laboratory Medicine’s (DPLM) requirements with respect to the capital purchase of an analyser (s) to replace current in use instrument(s) in the National Newborn Bloodspot Screening Laboratory (NNBSL) at Children's Health Ireland (CHI) at Temple Street, Temple Street, Dublin 1.
Tender incorporates a system which MUST be capable at a minimum of performing the following Newborn Bloodspot Screens (NBS) on 3.2 mm dried blood spot (DBS) samples.
1. Congenital Hypothyroidism (CHT) screening by thyroid stimulating hormone (TSH) measurement
2. Cystic Fibrosis (CF) screening by immunoreactive trypsinogen (IRT) measurement
3. Galactosaemia screening by
• Total galactose (galactose and galactose-1-phosphate) and
• Galactose-1-phosphate uridyl transferase enzyme (GALT) analysis
Must interfacable toSpecimen Gate™.
All associated consumable must also be included within submission.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 400000.00  EUR
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 60
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  18/12/2020
Local time:  14:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.6)

Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until:  18/12/2021
IV.2.7)

Conditions for opening of tenders

Date:  18/12/2020
Local time:  14:00
Place:  
CHI TEMPLE STREET
Information about authorised persons and opening procedure:  
CONTRACTS & PROCUREMENT MANAGER + AUTHORISED OFFICER

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  yes
Estimated timing for further notices to be published:  
60 Months
VI.2)

Information about electronic workflows

Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4)

Procedures for review

VI.4.1)

Review body

Children's Health Ireland
Temple Street
Dublin 1
Dublin 1
IE
Telephone: +353 18784877